-
21.
公开(公告)号:US20170105631A1
公开(公告)日:2017-04-20
申请号:US15296150
申请日:2016-10-18
Applicant: COVIDIEN LP
Inventor: Paul Stanley Addison , James N. Watson , Dean Montgomery
IPC: A61B5/0205 , A61B5/00 , A61B5/145 , A61B5/1455 , A61B5/021 , A61B5/026
CPC classification number: A61B5/0205 , A61B5/0059 , A61B5/02028 , A61B5/021 , A61B5/026 , A61B5/0261 , A61B5/031 , A61B5/14546 , A61B5/14553 , A61B5/4064 , A61B5/7246 , A61B5/742 , A61B5/7425 , A61B5/743 , G16H40/63 , G16H50/20 , G16H50/30
Abstract: A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.
-
公开(公告)号:US20170065484A1
公开(公告)日:2017-03-09
申请号:US15259668
申请日:2016-09-08
Applicant: COVIDIEN LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61H31/00 , A61B5/0205 , A61N1/39 , A61B5/00
CPC classification number: A61H31/005 , A61B5/0205 , A61B5/0261 , A61B5/0402 , A61B5/14551 , A61B5/4848 , A61B5/7264 , A61B5/7282 , A61H2201/5043 , A61H2201/5048 , A61H2201/5092 , A61H2230/06 , A61H2230/207 , A61H2230/40 , A61N1/3925
Abstract: A method for determining an efficacy of cardiopulmonary resuscitation (CPR) includes receiving a plethysmography signal from an oximetry sensor and an electrocardiogram (ECG) signal from an ECG sensor at a processor associated with a patient monitor, the oximetry sensor, or the ECG sensor. The method includes determining a first indicator related to the efficacy of CPR based on the plethysmography signal, using the processor. The method also includes determining a second indicator related to the efficacy of CPR based on the ECG signal, using the processor. The method further includes combining the first indicator and the second indicator to determine a combination metric indicative of the efficacy of CPR, using the processor.
Abstract translation: 用于确定心肺复苏(CPR)的功效的方法包括从与患者监测器,血氧测定传感器或ECG传感器相关联的处理器处接收来自血氧测定传感器的体积描记信号和来自ECG传感器的心电图(ECG)信号。 该方法包括使用处理器来确定与基于体积描记信号的CPR功效相关的第一指示符。 该方法还包括使用处理器来确定与基于ECG信号的CPR的功效相关的第二指示符。 该方法还包括使用处理器组合第一指示符和第二指示符以确定指示CPR的功效的组合度量。
-
公开(公告)号:US11317821B2
公开(公告)日:2022-05-03
申请号:US15702112
申请日:2017-09-12
Applicant: Covidien LP
Inventor: Paul Stanley Addison , Rui Wang , Scott McGonigle , James N. Watson
IPC: A61B5/02 , A61B5/0295 , A61B5/022 , A61B5/08 , A61B5/1455
Abstract: The present invention relates to physiological signal processing, and in particular to methods and systems for processing physiological signals to predict a fluid responsiveness of a patient. A medical monitor for monitoring a patient includes an input receiving a photoplethysmograph (PPG) signal representing light absorption by a patient's tissue. The monitor also includes a perfusion status indicator indicating a perfusion status of the PPG signal, and a fluid responsiveness predictor (FRP) calculator programmed to calculate an FRP value based on a respiratory variation of the PPG signal. The FRP calculator applies a correction factor based on the perfusion status indicator.
-
公开(公告)号:US20200345270A1
公开(公告)日:2020-11-05
申请号:US16936049
申请日:2020-07-22
Applicant: COVIDIEN LP
Inventor: PAUL STANLEY ADDISON , Daniel Wayne Bartlett , James N. Watson
IPC: A61B5/091 , A61B5/0456 , A61B5/053 , A61B5/00
Abstract: Methods, systems, and devices for measuring respiratory parameters from an ECG device are described. The method may include receiving an electrocardiogram (ECG) signal associated with a patient. The method may further include detecting a change in modulation of the ECG signal between a first portion of the ECG signal and a second portion of the ECG signal. The method may further include determining a change in respiratory effort of the patient based at least in part on the change in modulation.
-
公开(公告)号:US20190269853A1
公开(公告)日:2019-09-05
申请号:US16417885
申请日:2019-05-21
Applicant: Covidien LP
Inventor: Peter Doyle , Paul S. Addison , James N. Watson
IPC: A61M5/172 , A61B5/00 , A61B5/08 , A61B5/1455
Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
-
公开(公告)号:US10328202B2
公开(公告)日:2019-06-25
申请号:US15006018
申请日:2016-01-25
Applicant: Covidien LP
Inventor: Peter Doyle , Paul S. Addison , James N. Watson
IPC: A61M5/172 , A61B5/08 , A61B5/1455 , A61B5/00 , A61B5/024
Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
-
公开(公告)号:US10299734B2
公开(公告)日:2019-05-28
申请号:US15281561
申请日:2016-09-30
Applicant: COVIDIEN LP
Inventor: James N. Watson , Daniel Bartlett , Paul S. Addison
IPC: A61B5/0205 , A61B5/00 , A61B5/1455 , A61B5/024 , A61B5/08 , A61B5/11
Abstract: A system may include a photoplethysmograph (PPG) sensor configured to be secured to a patient and to generate a PPG signal for the patient. The system may also include a motion sensor configured to generate a motion signal indicative of motion of the patient. Further, the system may include a controller configured to receive the PPG signal from the PPG sensor and the motion signal from the motion sensor, to analyze the motion signal to detect motion of the patient, and to deactivate the at least one emitter of the PPG sensor based on the analysis of the motion signal when motion of the patient is detected.
-
公开(公告)号:US10292663B2
公开(公告)日:2019-05-21
申请号:US15194122
申请日:2016-06-27
Applicant: COVIDIEN LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61B5/00 , A61B5/021 , A61B5/1455 , A61B5/0205 , A61B5/0225 , A61B5/0285 , A61B5/022 , A61B5/024 , G16H50/30 , G16H50/50
Abstract: A method for monitoring autoregulation includes receiving a blood pressure signal and an oxygen saturation signal, determining a phase difference between the blood pressure signal and the oxygen saturation signal, and determining a patient's autoregulation status based at least in part on a phase difference between the blood pressure signal and the oxygen saturation signal.
-
公开(公告)号:US09955894B2
公开(公告)日:2018-05-01
申请号:US14606943
申请日:2015-01-27
Applicant: Covidien LP
Inventor: Paul S. Addison , James N. Watson
IPC: A61B5/04 , A61B5/0476 , A61B5/00
CPC classification number: A61B5/0476 , A61B5/4821 , A61B5/726
Abstract: Methods and systems are presented for determining physiological information in a physiological monitor. A physiological signal (e.g., an EEG signal) received from a subject is wavelet transformed and first and second related features that vary in scale over time are identified in the transformed signal. First and second coupled ridges of the respective first and second related features may also be identified in the transformed signal. A non-stationary relationship parameter is determined and is indicative of the relationship between the first and second features and/or between the first and second ridges. Physiological information, which may be indicative of a level of awareness of a subject, is determined based on the non-stationary relationship parameter. This physiological information may be used, for example, in an operating room to monitor/regulate the subject's anesthetic state while under general anesthesia or in an intensive care unit to monitor the subject's sedateness and administer medication accordingly.
-
公开(公告)号:US20170196501A1
公开(公告)日:2017-07-13
申请号:US14993856
申请日:2016-01-12
Applicant: COVIDIEN LP
Inventor: James N. Watson , Paul S. Addison
IPC: A61B5/00 , A61B5/1455 , G06F19/00 , A61B5/0476
CPC classification number: A61B5/4821 , A61B5/0476 , A61B5/14551 , A61B5/7221 , G16H10/60 , G16H40/63 , G16H50/30
Abstract: A patient monitor for monitoring cerebral activity of a patient may include a processor configured to determine a depth of consciousness index for the patient based on electroencephalography (EEG) data and determine regional oxygen saturation for the patient based on regional oximetry data. Additionally, the processor may be configured to determine a metric associated with cerebral activity of the patient based at least in part on the one or more values of the depth of consciousness index and the one or more regional oxygen saturation values and to provide the one or more values of a depth of consciousness index and the metric to an output device.
-
-
-
-
-
-
-
-
-